premargin

Qomel Company received a No-Notification Required Certificate from the General Authority for Competition for the acquisition of a 75% stake in Kan Medical Company.
Dhirwah Financial Advisory has been appointed as the financial advisor for the transaction.
The final purchase price for the acquisition will be determined after completing financial, legal, and technical due diligence.
The acquisition targets Kan Medical Company, a specialist in medical device manufacturing, to strengthen Qomel's presence in the sector.

Element List	Explanation
Introduction	With reference to the announcement published by Qomel Company on 22/07/1447H corresponding to 11/01/2026 regarding the signing of a non-binding Memorandum of Understanding with Kan Medical Company to acquire a stake ranging from 60% to 90% of the shares of Kan Medical Company, a Limited Liability Company (Single Shareholder). Accordingly, the Company is pleased to announce that it has received a No-Notification Required Certificate issued by the General Authority for Competition for the acquisition of a stake representing 75% of the capital of Kan Medical Company. The Company would also like to announce the appointment of Dhirwah Financial Advisory as the financial advisor for the transaction.
Previous Announcement	Announcement by Qomel Company regarding the signing of a non-binding Memorandum of Understanding with Kan Medical Company to acquire a stake ranging from 60% to 90% of the shares of Kan Medical Company, a Limited Liability Company (Single Shareholder).
Date of Previous Announcement on Saudi Exchange’s Website	2026-01-11 Corresponding to 1447-07-22
Hyperlink to the Previous Announcement on the Saudi Exchange Website	Click Here
Latest Developments Of The Announced Event	Announcement by Qomel Company regarding the signing of a non-binding Memorandum of Understanding with Kan Medical Company to acquire a stake ranging from 60% to 90% of the shares of Kan Medical Company, a Limited Liability Company (Single Shareholder).
The costs associated with the event, and if they have changed or not with indication of the reasons.	There is no change in the previously announced costs.
Additional Information	It is worth noting that Kan Medical Company is a company specialized in the manufacturing of medical devices. Through this step, Qomel aims to strengthen its presence in the medical devices sector, expand its business base, and benefit from the growing opportunities in this sector. The final purchase price will be determined after completing the financial valuation and due diligence process (financial, legal, and technical). It should also be noted that the Memorandum of Understanding is non-binding and does not impose any obligation on Qomel Company if the transaction is not completed or is withdrawn for any reason.

Element List

Explanation

Introduction

With reference to the announcement published by Qomel Company on 22/07/1447H corresponding to 11/01/2026 regarding the signing of a non-binding Memorandum of Understanding with Kan Medical Company to acquire a stake ranging from 60% to 90% of the shares of Kan Medical Company, a Limited Liability Company (Single Shareholder).

Accordingly, the Company is pleased to announce that it has received a No-Notification Required Certificate issued by the General Authority for Competition for the acquisition of a stake representing 75% of the capital of Kan Medical Company. The Company would also like to announce the appointment of Dhirwah Financial Advisory as the financial advisor for the transaction.

Previous Announcement

Announcement by Qomel Company regarding the signing of a non-binding Memorandum of Understanding with Kan Medical Company to acquire a stake ranging from 60% to 90% of the shares of Kan Medical Company, a Limited Liability Company (Single Shareholder).

Date of Previous Announcement on Saudi Exchange’s Website

2026-01-11 Corresponding to 1447-07-22

Hyperlink to the Previous Announcement on the Saudi Exchange Website

Click Here

Latest Developments Of The Announced Event

The costs associated with the event, and if they have changed or not with indication of the reasons.

There is no change in the previously announced costs.

Additional Information

It is worth noting that Kan Medical Company is a company specialized in the manufacturing of medical devices. Through this step, Qomel aims to strengthen its presence in the medical devices sector, expand its business base, and benefit from the growing opportunities in this sector. The final purchase price will be determined after completing the financial valuation and due diligence process (financial, legal, and technical). It should also be noted that the Memorandum of Understanding is non-binding and does not impose any obligation on Qomel Company if the transaction is not completed or is withdrawn for any reason.

Announcement by Qomel Company regarding the latest developments on the signing of a non-binding Memorandum of Understanding with Kan Medical Company to acquire a stake ranging from 60% to 90% of the shares of Kan Medical Company, a Limited Liability Company (Single Shareholder).